INTRODUCTION
============

Probiotics are live microorganisms when consumed in certain number provide health benefits beyond inherent basic nutrition \[[@b1-ir-2018-00106]\]. The most commonly used microbial genera in probiotic preparations are *Lactobacillus*, *Bifidobacterium*, *Enterococcus*, *Bacillus*, *Streptococcus*, and *Saccharomyces*. These strains have been reported for their effectiveness in varied clinical conditions---such as infantile diarrhea, necrotizing enterocolitis (NEC), antibiotic-associated diarrhea, relapsing *Clostridium difficile* colitis, *Helicobacter pylori* infections, inflammatory bowel and female urogenital infection \[[@b2-ir-2018-00106]\]. Apart from the GI disorders, the probiotics also promote a healthy gut microbiome, balanced immune function and enhanced nutrient absorption leading to a healthy host. The probiotics are also reported for their antimicrobial activities against the pathogens in GI tract via production of antimicrobial compounds (organic acids, hydrogen peroxide, bacteriocins), competing for nutrients and adhesion sites on host, decreasing luminal pH \[[@b3-ir-2018-00106]\].

*Cronobacter sakazakii* is an emerging foodborne pathogen, causing life-threatening forms of neonatal meningitis, sepsis, and NEC in newborn and premature infants \[[@b4-ir-2018-00106]\], with a fatality rate of 40% to 80% \[[@b5-ir-2018-00106]\]. In addition to its high-fatality rate, it may also result in severe neurological sequelae such as quadriplegia, hydrocephalus and retarded neural development in survivors \[[@b6-ir-2018-00106]\]. The environmental source of *C. sakazakii* is not evidently understood; however, the epidemiological studies implicate reconstituted powdered infant formula (PIF) as the possible source of transmission \[[@b7-ir-2018-00106]\]. Survival of bacteria in such a dry environment largely depends on the osmotic and/or dry stress resistance of the bacteria \[[@b8-ir-2018-00106]\]. Our laboratory has previously reported the prevalence of *C. sakazakii* among different food and environmental commodities. The isolates expressed different virulent factors such as hemolytic and chitinase activity along with the presence of genes encoding for hemolysin, outer membrane protein (*ompA*), *Cronobacter* plasminogen activator (*cpa*) and ferric ion transporter protein (*eitA*) \[[@b9-ir-2018-00106]-[@b11-ir-2018-00106]\]. Apart from expression of these virulent traits, the isolates were able to form biofilm mediated by expression of acyl homoserine lactones as signaling molecules and genes encoding for cellulose synthesis \[[@b11-ir-2018-00106]\].

Although probiotic cultures have been reported for their antimicrobial activities against an array of pathogens leading the GI disorders, however, very few studies have been conducted to check the efficacy of probiotics against *C. sakazakii* \[[@b12-ir-2018-00106],[@b13-ir-2018-00106]\]. The commercial probiotic products are usually used to treat the diarrheal infections caused by gram negative pathogens, therefore, it is imperative to investigate the efficacy of these probiotics for their antimicrobial activities against *C. sakazakii*. To achieve this goal, the present study was designed to isolate pure strains of probiotics from commercial products and to investigate the anti-biofilm activities of cell-free supernatant (CFS) against biofilm forming *C. sakazakii*. The microscopic observations were also made to decipher the changes in the biofilm structure as induced by CFS.

METHODS
=======

1. Probiotic Products and Cultures
----------------------------------

A total of 6 different commercial probiotic supplements marketed in India were collected from local retailers ([Table 1](#t1-ir-2018-00106){ref-type="table"}). All of the products except Yakult were in the powder formulation (sachets). The lactic acid bacteria from these products were isolated on de Man, Rogosa, Sharpe (MRS) agar plates. Colonies were differentiated according to their shape, size and other morphological features. The individual colonies obtained on MRS agar were further subcultured on MRS agar to get pure cultures. The cultures were tentatively identified based on Grams reaction and catalase test. The standard strain *C. sakazakii* ATCC 12868 used in the study was kindly gifted by Dr. Davis Tall Ben, FDA, USA \[[@b9-ir-2018-00106]\]. The indicator strain, available as glycerol stock was revived, subcultured in Tryptone Soya Broth (TSB) and checked for purity.

2. Antibiotic Susceptibility Test for Isolated Probiotic Cultures
-----------------------------------------------------------------

The susceptibility of different isolates to antibiotics was determined by disk diffusion method as per the recommendations of National Committee for Clinical Laboratory Standards \[[@b14-ir-2018-00106]\]. The overnight grown cultures of probiotic isolates (OD~600\ nm~ =0.5) were spread on Muller Hinton agar plates (HiMedia Laboratories, Mumbai, India). The antibiotic discs were placed on the cultured plates and incubated for 24 hours at 37°C. The diameter of inhibition zones were measured and the results were expressed as sensitive (S) and resistant (R) as per EFSA, 2008 \[[@b15-ir-2018-00106]\].

3. Antimicrobial Activity of CFS against *C. sakazakii*
-------------------------------------------------------

The antimicrobial activity of CFS of overnight grown probiotic cultures was tested against *C. sakazakii* using agar well assay. The overnight grown probiotic strains in MRS broth were centrifuged (2000 ×g for 5 minutes) and the spent medium was collected in fresh tubes. The spent culture medium was filtered through 0.22 μM nylon membrane filters (Millipore, Burlington, MA, USA). The CFS obtained was given 2 treatments: neutralization to a pH of 7.0 by addition of 1 N sodium hydroxide (NaOH) and a heat treatment of 100°C for 5 minutes to obtain neutralized (N-CFS) and heat-treated (H-CFS) preparations respectively. All the 3 CFSs (CFS, N-CFS, and H-CFS) were stored at --80°C until further use. The un-inoculated MRS broth was taken as control.

For antimicrobial assay, the indicator strain of *C. sakazakii* was grown to exponential phase (OD~600\ nm~ =0.5) in TSB and spread on the TSA plate. After spreading, wells were punched in the agar plates and the wells were filled with 100 μL of all the 3 CFS preparations along with the control MRS broth. The plates were incubated at 35°C for 12 hours and the diameter of zones of inhibition (mm) was determined.

4. Minimum Bactericical Concentration of CFS against *C. sakazakii*
-------------------------------------------------------------------

The minimum bactericidal concentrations (MBCs) of CFS were determined in microtitre plates by micro dilution assay as per the protocol of Clinical and Laboratory Standards Institute. The untreated CFS was diluted in the range of 0.13 to 0.250 of total volume in TSB. Briefly, a bacterial inoculum (10 μL, OD~600\ nm~ =0.5) was added the microtitre plates containing TSB, followed by addition of different concentrations of CFS. TSB alone in the wells was used as a negative control. The final volume of each well was 250 μL. The plates were incubated at 37°C for 24 hours and absorbance was measured at 600 nm. Among the tested probiotic derived CFS, only 4 CFS samples indicated effective inhibition of growth of *C. sakazakii* at a concentration of 50 μL, therefore, for further biofilm inhibition assay, only 4 strains were tested.

5. Anti-Biofilm Activity of the CFS
-----------------------------------

The anti-biofilm potential of CFS from isolated probiotic strains was determined in polystyrene flat-bottom 96-well microtiter plates using crystal violet (CV) staining assay \[[@b16-ir-2018-00106]\]. In brief, a 10 μL cell suspension of *C. sakazakii* indicator strain (OD~600\ nm~=0.5) was incubated along with CFS (40 μL each) for inhibition of biofilm formation at different time period. The plates were incubated for 48 hours at 37°C. After a time, interval of 12, 24, and 48 hours of incubation, the planktonic cell suspension was aspirated and wells were washed with phosphate buffered saline (1×PBS) to remove loosely adherent cells. The surface adhered cells were stained with 200 μL of 0.2% CV solution for 15 minutes at room temperature. Following staining, CV solution was decanted and the stained cells were solubilized with 250 μL of 33% glacial acetic acid. The biofilm biomass was then quantified by measuring the intensity of CV at OD~570\ nm~ using a Multiskan Go microplate reader (Thermo Fischer Scientific, Waltham, MA, USA).

The anti-biofilm activity (%) was calculated following the formula: anti-biofilm activity (%)=(control OD~570\ nm~ − test OD~570\ nm~/control OD~570\ nm~) ×100. The un-inoculated MRS broth was taken as negative control.

6. Visualization of Biofilms
----------------------------

### 1) Light Microscopic Analysis

The biofilm of indicator *C. sakazakii* strain was developed on glass cover slips (1×1 cm). The strain was grown in 6-well tissue culture plate containing sterile glass cover slips, TSB (1,680 μL/well) and CFSs from different lactic acid bacterial strains (240 μL/well). The wells without CFS were taken as control. The plates were incubated for 48 hours at 37°C. After 24 hours, the planktonic cells were removed and cover slips were rinsed with phosphate buffer (pH 6.5) and were stained with 0.2% CV solution for 30 minutes. The excess of stain was washed twice with distilled water and the slides were air dried. The stained cover slips were visualized under light microscope at ×40 magnification (Olympus Microscope, Tokyo, Japan).

### 2) Fluorescent Microscopy

For the fluorescent microscopic images, the biofilms were treated as discussed before. After the treatment of biofilms, the cover slips were stained with LIVE/DEAD Bac Light bacterial viability kit (L10316; Invitrogen-Molecular Probes, Waltham, MA, USA). The kit included mixture of 2 fluorescence dyes: SYTO 9 (green-fluorescent nucleic acid stain) and propidium iodide (red-fluorescent nucleic acid stain). The viable bacterial cells with a healthy or intact membrane stain green, whereas dead cells or cells with a damaged membrane stain fluorescent red. The stained coverslips were observed at ×400 magnification using a fluorescence microscope BX53 (Olympus Microscopy) equipped with imaging system Qiclick™ (Olympus).

7. Statistical Analysis
-----------------------

Each experiment was conducted in triplicate at 3 different time points and the data were represented as mean values (n=9). The statistical significance among the treatments was conducted using ANOVA and Tukey multiple comparison test (*P*\<0.05) with SPSS version 21.0 (IBM Corp., Armonk, NY, USA).

RESULTS
=======

1. Probiotic Bacterial Isolates
-------------------------------

A total of 6 distinct colonies were obtained on MRS agar plates. All the cultures were Gram positive rods, responded negative to catalase test except one isolate from Bifilac which was Gram positive cocci. The isolates tested in the present study were *Streptococcus faecalis* (Bifilac), *Lactobacillus sporogenes* (Vizylac, Vibact, Caplac), *Lactobacillus* sp (Rinifol) and *Lactobacillus casei* strain Shirota (Yakult) ([Table 1](#t1-ir-2018-00106){ref-type="table"}).

2. Antibiotic Susceptibility of Lactic Cultures
-----------------------------------------------

The isolated cultures were tested for their antibiotic susceptibility pattern. Varying pattern of antibiotic susceptibility was obtained with probiotic culture isolated from commercial probiotic products. The antibiotic susceptibility profile is presented in [Table 2](#t2-ir-2018-00106){ref-type="table"}. Most of the strains were resistant to erythromycin and novobiocin. All the isolated strains were sensitive to ampicillin, tetracycline, vancomycin and carbenicillin.

3. Antimicrobial Activity of CFS against *C. sakazakii*
-------------------------------------------------------

The antimicrobial activity of probiotic isolates was determined by determining the growth inhibition of *C. sakazakii* in the presence of CFS of probiotic isolates ([Table 3](#t3-ir-2018-00106){ref-type="table"}). The results indicated that untreated and heat treated CFS from all the cultures inhibited the growth of *C. sakazakii* with an inhibition zone ranging between 10 and 14 mm ([Supplementary Fig. 1](#SD1-ir-2018-00106){ref-type="supplementary-material"}). No zone of inhibition was observed using neutralized CFS expect for the *L. sporogenes* obtained from Vizylac.

4. MBC of CFS against *C. sakazakii*
------------------------------------

The MBC assay revealed different susceptibilities of indicator organisms to the CFS of probiotic strains, and exhibited potent inhibitory effect as represented as MBC values ([Table 4](#t4-ir-2018-00106){ref-type="table"}). From this MBC assay, it was observed that a 50 μL concentration of CFS resulted in complete inhibition of *C. sakazakii*, therefore, a concentration of 40 μL of CFS was used for further experiments.

5. Biofilm Inhibition Potential
-------------------------------

The biofilm inhibitory activities of the CFS of lactic cultures at diferent time interval is presented in [Table 5](#t5-ir-2018-00106){ref-type="table"}. Similar to the antimicrobial activity, the CFS possessed varying degree of biofilm inhibitory activity. The higher inhibiton was observed at intial incubation of 12 hours (\> 80%) after which there was weaker anti-biofilm activity after 24 and 48 hours of incubation (50%--60%) for all the strains (*P*\>0.05).

6. Microscopic Observations
---------------------------

The stained microscopic observations revealed a clear difference between the treated and the control biofilm of *C. sakazakii* ([Figs. 1](#f1-ir-2018-00106){ref-type="fig"} and [2](#f2-ir-2018-00106){ref-type="fig"}). The microscopic images showed that the CFS reduced the adhesion of bacterial cell to the glass cover slips. The control slides indicated a uniform, consistent and well-developed biofilm whereas the slides treated with CFS were observed to have scattered biofilm.

DISCUSSION
==========

*C. sakazakii* is an emerging life-threatening food borne pathogen usually implicated in reconstituted PIF and dairy products resulting in life-threatening forms of neonatal meningitis, sepsis, and NEC in newborn and premature infants and immune-compromised adults \[[@b9-ir-2018-00106]\]. The pathogen is also able to survive under harsh food processing conditions due its ability to form biofilm on abiotic surfaces \[[@b9-ir-2018-00106],[@b16-ir-2018-00106]-[@b19-ir-2018-00106]\]. As the pathogen is mainly implicated in the milk formula therefore, the lactic acid bacteria usually present in dairy sources can be used to prevent the growth and biofilm inhibitory activities. Therefore, this study was designed to test the probiotic cultures derived from commercial preparations used in diarrheal infections, for their antimicrobial activities against *C. sakazakii*.

All the isolates obtained from commercial preparation belonged to lactic acid bacteria group. Regarding the safer use of probiotics for human consumption, horizontal gene transfer of antibiotic resistance gene harbored by these cultures is of major concern, therefore, the determination of antibiotic susceptibility is one of the important safety concerns for the probiotic cultures applications \[[@b20-ir-2018-00106]\]. All the lactic cultures obtained from commercial preparation were tested for their susceptibility pattern to different antibiotic. All the probiotic strains were sensitive to ampicillin, tetracycline, vancomycin and carbenicillin whereas most of the strains were resistant to erythromycin and novobiocin. The *Lactobacillus* isolates from Yakult and Vibact were the most sensitive strains to the tested antibiotics. The isolate obtained from Rinifol was the strain possessing resistance towards many tested antibiotics. However, as reported for the lactic cultures towards their intrinsic resistance to vancomycin, we did not observe any resistance to vancomycin in isolates. The intrinsic resistance in the probiotic strains may be considered as beneficial as it will allow them to maintain the microbial ecological balance in gut during antibiotic therapy \[[@b21-ir-2018-00106]\].

The spent culture medium from isolated probiotics was further tested for its antimicrobial and anti-biofilm activities against the *C. sakazakii* as indicator strain. Along with the untreated CFS, all the heat neutralized cell supernatants of all cultures also inhibited the growth of the indicator strain. The results indicated that the inhibitory substance(s) in the CFSs were heatresistant as activity was not abolished after heat treatment. Except neutralized CFS from *L. sporogenes* isolated from Vizylac, no zone of inhibition was observed with other cultures indicating that there might be a possible role of metabolites/products such as bacteriocins for this culture other than organic acids which resulted in antimicrobial activities. Results indicated that in most of the cases the inhibitory effect of lactobacilli may be resulted from the production of antibacterial organic acid molecules or antibacterial agents such as bacteriocin that are active in acid condition \[[@b22-ir-2018-00106]\]. Many other studies have reported that the inhibition of food-borne pathogens by probiotic lactic cultures can be mediated by competitive exclusion or production of antimicrobial metabolites such as organic acids, hydrogen peroxide and antimicrobial peptides (e.g., bacteriocins) \[[@b23-ir-2018-00106],[@b24-ir-2018-00106]\]. Regarding the antimicrobial activities of lactic cultures against *C. sakazakii*; Hayes et al. \[[@b25-ir-2018-00106]\], assessed the activity of sodium caseinate fermentate (obtained from the fermentation of sodium caseinate with the proteolytic strain of *Lactobacillus acidophilus* DPC 6026) for decreasing the numbers of *Cronobacter* spp. in reconstituted PIF. At higher final concentrations of fermentate (3.33% w/v), numbers were completely eliminated from 6 logs CFU/mL over an incubation time of 60 minutes. Similarly, Awaisheh et al. \[[@b26-ir-2018-00106]\], reported the antimicrobial activity of pH-neutralized CFS of *L. acidophilus* or *L. casei* (isolated from faces of infants) against tested *C. sakazakii*. They also reported that the inhibition was due to the production of bacteriocins by *L. acidophilus* and *L. casei*. Recently, Kim et al. \[[@b27-ir-2018-00106]\], has also reported the antimicrobial activity of *Lactobacillus kefiri* DH5 against *C. sakazakii* due to production of organic acids. The CFS was reported to disrupt the cellular membrane integrity and induce leakage of cytoplasmic materials including nucleic acid and proteins. Yi et al. \[[@b28-ir-2018-00106]\], have reported the antagonistic activity of a bacteriocin preparation from *Lactobacillus crustorum* MN047 disrupting the integrity of cell envelope leading to cell membrane permeabilization.

As reported before, the *C. sakazakii* strain used in the present study start forming biofilm after 12 hours of inucbation and a mature biofilm is formed after 48 hours of incubation \[[@b16-ir-2018-00106]\], therefore, the anti-biofilm activity of the probiotic isolates against *C. sakazakii* was evaluated at different stages of biofilm formation (12--48 hours). The basis for the suppression of biofilm formation by *C. sakazakii* with CFS from different strains may be attributed to the presence of certain metabolites in the CFS as previously bacteriocins/metabolic products from lactobacilli are reported to induce unfavourable situation for the development of biofilm by pathogenic bacteria \[[@b29-ir-2018-00106]-[@b32-ir-2018-00106]\]. The CFS tested in this study possessed higher inhibition at initial stages of biofilm formation and were weaker to suppress/eliminate the biofilm at later stages, suggested the effects on the biofilms might be physicochemical or more particularly, interfacial in nature. The biosurfactants in metabolites liberated by lactobacilli are reported to interfere with the adhesion of cells, since these decrease the hydrophobicity of the surface substratum and obstruct with progressions related to microbial adhesion and desorption \[[@b33-ir-2018-00106]-[@b35-ir-2018-00106]\]. The ability to disrupt biofilm formation process of *C. sakazakii* with CFS from lactic cultures was also assessed by microscopic observations. Representative light microscopic and fluorescent images indicated disruptive effects of CFS by interfering with bacterial attachment and destabilizing the biofilm matrix. Candela et al. \[[@b36-ir-2018-00106]\] reported that different strains of probiotic bacteria (*Lactobacillus plantarum* Bar10, *L. acidophilus* Bar13, *Bifidobacterium lactis* Bar30 and *Bifidobacterium longum* Bar33) were capable of obstructing the adhesion sites for enteropathogens Escherichia coli H10407 and *Salmonella typhimurium* on Caco-2 cell line. In another study, the extracellular polysaccharides liberated from *L. acidophilus* A4 declined biofilms of enterohemorrhagic *E. coli* *in vitro* by affecting genes related to chemotaxis and curli production \[[@b37-ir-2018-00106]\]. These may also alter the biofilm integrity *via* interference with cell-to-cell aggregation and surface attachment processes. This effect may be mediated by the exopolysaccharides release by lactic cultures or by the physicochemical properties of their cell surface \[[@b38-ir-2018-00106],[@b39-ir-2018-00106]\].

In conclusions, the pathogens such as *C. sakazakii* possessing biofilm mediated tolerance to different food processing conditions continue to pose risk to human health. For the effective control of biofilm formation process of *C. sakazakii*, probiotic lactobacilli are suitable candidate as described in this study. The outcome of this study will provide appropriate measures to be taken by health care providers for recommending probiotics against infection by the pathogen. Such information will be of interest to regulatory agencies for food production units where heating processes or other processing conditions are not sufficient to kill the target pathogen. However, further studies are needed to identify the functional moiety in the crude CFS to promote its application in biocontrol of biofilm mediated stress responses in *C. sakazakii*.
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SUPPLEMENTARY MATERIAL
======================

###### 

Supplementary Fig. 1. Antimicrobial activity of different fractions of cell-free supernatant (CFS) against *Cronobacter sakazakii* using agar well assay. H, heat neutralized CFS; C, untreated CFS; pH, pH neutralized CFS.

![(A-D) Effect of cell-free supernatant from probiotic cultures on biofilm formation by *Cronobacter sakazakii* stained with crystal violet staining (arrows indicate disrupted biofilm at different hours of incubation) at ×40.](ir-2018-00106f1){#f1-ir-2018-00106}

![Fluorescent microscopic images of effect of cell-free supernatant (CFS) from probiotics on biofilms of *Cronobacter sakazakii* grown at different stages using live-dead stain at 50 μm. (A) Stained with SYTO-9, (B) slides stained with propidium Iodide (PI), (C) merged image.](ir-2018-00106f2){#f2-ir-2018-00106}

###### 

Details of the Probiotic Products Procured for the Study

  Probiotic product   Compositions                                                                                                                                Date of manufacture   Expire date     Lot no.
  ------------------- ------------------------------------------------------------------------------------------------------------------------------------------- --------------------- --------------- ----------------
  Yakult              *Lactobacillus casei* strain Shirota                                                                                                        May 2017              June 2017       11110MFA
  Vizylac             *Lactobacillus sporogenes*: 40 M spores                                                                                                     November 2017         April 2019      DVC-17096
  Bifilac             *L. sporogenes*: 50 M cells, *Streptococcus faecalis*: 30 M cells, *Clostridium butyricum*: 2 M cells, *Bacillus mesentericus*: 1 M cells   May 2017              October 2018    ALA711
  Rinifol             *Lactobacillus* sp: 40 M spores                                                                                                             July 2017             February 2019   CDD110619
  Vibact              *B. mesentericus*: 1 M spores, *C. butyricum*: 2 M spores, *L. sporogenes*: 5 M spores, *S. faecalis*: 30 M spores                          October 2017          March 2019      BA7O2
  Caplac              *L. sporogenes*: 60 M spores                                                                                                                November 2016         April 2018      10916011000167

M, millions; sp, species.

###### 

Antibiotic Susceptibility of Probiotic Cultures Using Agar Disk Diffusion Assay

  Isolates                               Source    C   RIF   AMC   B   TE   HLG   E   NV   CB   VA   CEP   AK   CD   S   AMP
  -------------------------------------- --------- --- ----- ----- --- ---- ----- --- ---- ---- ---- ----- ---- ---- --- -----
  *Lactobacillus casei* strain Shirota   Yakult    S   S     R     S   S    S     S   R    S    S    S     S    R    S   S
  *Lactobacillus sporogenes*             Vizylac   S   R     S     R   S    R     S   R    S    S    R     I    R    I   S
  *Streptococcus faecalis*               Bifilac   S   S     S     R   S    S     R   R    S    S    I     I    R    R   S
  *Lactobacillus* species                Rinifol   R   R     R     R   S    S     R   R    S    S    S     I    R    I   S
  *L. sporogenes*                        Vibact    S   S     S     S   S    S     R   I    S    S    S     I    R    I   S
  *L. sporogenes*                        Caplac    S   S     S     R   S    S     R   R    S    S    S     I    R    I   S

In the table, S is susceptible, R is resistant, and I is intermediate.

C, chloramphenicol 30 units/disk; RIF, rifampicin 5 μg/disk; AMC, amoxiclav 30 μg/disk; B, bacitracin 10 units/disk; TE, tetracycline, 30 μg/disk; HLG, gentamycin 120 μg/disk; E, erythromycin 15 units/disk; NV, novobiocin 30 μg/disk; CB, carbenicillin 100 μg/disk; VA, vancomycin 30 μg/disk; CEP, cephalothin 30 μg/disk; AK, amikacin 30 μg/disk; CD, clindamycin 2 μg/disk; S, streptomycin 10 μg/disk; AMP, ampicillin 30 μg/disk.

###### 

Antimicrobial Activities in Terms of Zone of Inhibition (mm) of Probiotic Isolates against *Cronobacter sakazakii* Using Agar Well Assay

  Isolates                     Source    Supernatant     Heat neutralized   pH neutralized
  ---------------------------- --------- --------------- ------------------ ----------------
  *Lactobacillus* species      Yakult    12.3^a,x^±0.5   11.3^a,x^±1.1      \-
  *Lactobacillus sporogenes*   Vizylac   12.6^a,x^±1.1   11.3^a,x^±1.1      9.6^b,y^±0.5
  *Streptococcus faecalis*     Bifilac   12.3^a,x^±0.5   11.3^a,x^±0.5      \-
  *Lactobacillus* species      Rinifol   10.0^b,x^±0.1   10.3^b,x^±0.5      \-
  *L. sporogenes*              Vibact    10.6^b,x^±0.5   10.0^b,x^±0.1      \-
  *L. sporogenes*              Caplac    14.3^c,x^±0.5   12.3^a,y^±0.5      \-

^a-c^Means in the column with same superscript letter are not significantly different as measured by 2-sided Tukey *post-hoc* range test between replications.

^x,y^Means in the row with same superscript letter are not significantly different as measured by 2-sided Tukey *post-hoc* range test between replications.

###### 

Minimum Bactericidal Concentration Based on Optical Density (OD~600\ nm~) of CFS of Probiotic Isolates on Growth of *Cronobacter sakazakii*

  Isolates                     Source    CFS (30 µL)      CFS (40 µL)      CFS (50 µL)
  ---------------------------- --------- ---------------- ---------------- ----------------
  *Lactobacillus* species      Yakult    3.05^a,x^±0.08   2.20^b,y^±0.15   0.26^b,z^±0.12
  *Lactobacillus sporogenes*   Vizylac   2.99^a,x^±0.10   3.01^a,x^±0.10   3.01^a,x^±0.10
  *Streptococcus faecalis*     Bifilac   2.53^a,x^±0.35   1.84^c,y^±0.25   0.43^b,z^±0.05
  *Lactobacillus* species      Rinifol   2.89^a,x^±0.20   2.91^a,x^±0.15   2.81^a,x^±0.21
  *L. sporogenes*              Vibact    2.43^a,x^±0.30   1.61^c,y^±0.20   0.02^b,z^±0.04
  *L. sporogenes*              Caplac    2.59^a,x^±0.34   1.70^c,y^±0.14   0.21^b,z^±0.31

^a-c^Means in the column with same superscript letter are not significantly different as measured by 2-sided Tukey *post-hoc* range test between replications.

^x,z^Means in the row with same superscript letter are not significantly different as measured by 2-sided Tukey *post-hoc* range test between replications.

CFS, cell-free supernatant.

###### 

Biofilm Inhibition Potential (%) of Cell-Free Supernatant from Probiotic Isolates at Different Stages of Biofilm Formation by *Cronobacter sakazakii*

  Isolates                     Source    12 Hours      24 Hours      48 Hours
  ---------------------------- --------- ------------- ------------- -------------
  *Lactobacillus* species      Yakult    82^a,x^±2.6   57^b,y^±3.3   56^b,y^±2.8
  *Streptococcus faecalis*     Bifilac   85^a,x^±1.2   62^b,y^±5.1   62^b,y^±5.7
  *Lactobacillus sporogenes*   Vibact    96^a,x^±1.4   48^b,y^±3.0   51^b,y^±2.5
  *L. sporogenes*              Caplac    84^a,x^±3.1   60^b,y^±4.2   57^b,y^±4.1

^a-c^Means in the column with same superscript letter are not significantly different as measured by 2-sided Tukey *post-hoc* range test between replications.

^x,y^Means in the row for each time interval with same superscript letter are not significantly different as measured by 2-sided Tukey *post-hoc* range test between replications.

[^1]: These authors contributed equally to this study.
